22:18:00 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-02-29 Bokslutskommuniké 2023
2023-11-23 Kvartalsrapport 2023-Q3
2023-08-25 Kvartalsrapport 2023-Q2
2023-06-30 Årsstämma 2023
2023-05-31 Kvartalsrapport 2023-Q1
2023-05-05 Ordinarie utdelning RLS 0.00 SEK
2023-02-28 Bokslutskommuniké 2022
2023-02-09 Extra Bolagsstämma 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning RLS 0.00 SEK
2022-05-19 Årsstämma 2022
2022-05-11 Kvartalsrapport 2022-Q1
2022-02-25 Bokslutskommuniké 2021
2021-11-12 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-06-17 Årsstämma 2021
2021-05-27 Ordinarie utdelning RLS 0.00 SEK
2021-05-07 Kvartalsrapport 2021-Q1
2021-02-10 Bokslutskommuniké 2020
2020-11-12 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-05-27 Ordinarie utdelning RLS 0.00 SEK
2020-05-26 Årsstämma 2020
2020-05-15 Kvartalsrapport 2020-Q1
2020-02-14 Bokslutskommuniké 2019
2019-11-15 Kvartalsrapport 2019-Q3
2019-08-19 Extra Bolagsstämma 2019
2019-08-15 Kvartalsrapport 2019-Q2
2019-05-31 Ordinarie utdelning RLS 0.00 SEK
2019-05-29 Årsstämma 2019
2019-05-15 Kvartalsrapport 2019-Q1
2019-02-28 Bokslutskommuniké 2018
2018-11-30 Kvartalsrapport 2018-Q3
2018-08-31 Kvartalsrapport 2018-Q2
2018-06-14 Ordinarie utdelning RLS 0.00 SEK
2018-06-13 Årsstämma 2018
2018-05-31 Kvartalsrapport 2018-Q1
2018-02-28 Bokslutskommuniké 2017
2017-11-28 Kvartalsrapport 2017-Q3
2017-11-15 Extra Bolagsstämma 2017
2017-08-31 Kvartalsrapport 2017-Q2
2017-06-09 Ordinarie utdelning RLS 0.00 SEK
2017-06-08 Årsstämma 2017
2017-05-31 Kvartalsrapport 2017-Q1
2017-02-20 Bokslutskommuniké 2016
2016-11-30 Kvartalsrapport 2016-Q3
2016-08-31 Kvartalsrapport 2016-Q2
2016-06-01 Ordinarie utdelning RLS 0.00 SEK
2016-05-31 Kvartalsrapport 2016-Q1
2016-05-31 Årsstämma 2016
2016-02-29 Bokslutskommuniké 2015
2016-01-21 Extra Bolagsstämma 2016
2015-11-30 Kvartalsrapport 2015-Q3
2015-08-31 Kvartalsrapport 2015-Q2
2015-06-12 Ordinarie utdelning RLS 0.00 SEK
2015-06-11 Årsstämma 2015
2015-05-28 Kvartalsrapport 2015-Q1
2015-02-27 Bokslutskommuniké 2014
2014-11-28 Kvartalsrapport 2014-Q3
2014-09-12 Extra Bolagsstämma 2014
2014-08-29 Kvartalsrapport 2014-Q2
2014-06-10 Ordinarie utdelning RLS 0.00 SEK
2014-06-09 Årsstämma 2014
2014-05-23 Kvartalsrapport 2014-Q1
2014-03-05 Bokslutskommuniké 2013
2013-11-29 Kvartalsrapport 2013-Q3
2013-09-04 Kvartalsrapport 2013-Q2
2013-05-31 Kvartalsrapport 2013-Q1
2013-05-08 Split RLS 10:1
2013-04-11 Ordinarie utdelning RLS 0.00 SEK
2013-04-10 Årsstämma 2013
2013-03-05 Bokslutskommuniké 2012
2012-11-26 Kvartalsrapport 2012-Q3
2012-08-31 Kvartalsrapport 2012-Q2
2012-06-12 Ordinarie utdelning RLS 0.00 SEK
2012-06-11 Årsstämma 2012

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
RLS Global är verksamma inom bioteknik. Bolaget utvecklar biokemiska produkter och metoder för behandling av förekommande sår hos patienter. Bolagets produkter angriper skadad vävnad via den egenutvecklade teknologin som baseras på hypoklorit. Idag bedrivs forskning och utveckling inom vävnadsbaserad teknik. Bolaget har sitt huvudkontor i Göteborg.
2023-01-24 21:40:00

RLS Global AB announces today that Lars Johansson is nominated for election as new Chairman of the Board. Current Chairman Steve Krognes will step down and the change of Chairman is planned for an upcoming extraordinary general shareholder meeting.

Lars Johansson is an experienced Managing Director and board professional from the medical device and pharmaceutical industries. He brings significant leadership experience both from Sweden and internationally, and has worked at Johnson & Johnson for close to three decades in positions of increasing seniority and impact. His most recent previous experience includes CEO Nordics at Janssen-Cilag and CEO Nordics at Johnson & Johnson where he had leadership responsibility for several hundreds of people and several hundred million dollars of annual revenues. Lars brings a wealth of commercial experience and proven leadership skills. He is currently serving on the boards of Schain Research AB and ProstaLund AB.

"I look forward to joining RLS Global as Chairman and together with the Board and the RLS management team, to accelerate and realize the potential of RLS' unique, patented hypochlorite platform, ChloraSolv. I am convinced that ChloraSolv, which is available in several European markets, will contribute to improved and more efficient care for patients with hard to heal wounds. I am particularly looking forward to working closely with Björn Larsson and our key strategic commercial partners to help drive uptake of ChloraSolv across different geographies", says Lars Johansson.

Steve Krognes has served on the Board of RLS Global since 2018 and as Chairman since 2021.

"I am proud of the progress we have jointly achieved at RLS over the years, and in particular bringing an important, new product to patients in the underserved wound care market. With a new, experienced CEO in place and increasing commercial momentum for ChloraSolv through our partnerships, I believe this is a good time to bring in new leadership at the Board. As a significant owner of RLS Global, I remain committed to the company and its success going forward," says Steve Krognes.

The appointment of Lars Johansson as Chairman of the Board is planned for an extra general meeting on February [9], 2023. A formal notice will follow shortly. Lars Johansson is proposed to be elected as Chairman with immediate effect.

RLS Global (publ) is obliged to make the information contained herein public pursuant to the EU market abuse regulation (MAR). The information was submitted for publication through the agency of the above contact person, 24-01-2023 21:40 CET.